JENNIFER SOJOURNER: Open Payments
NPI 1679881312 · CRYSTAL SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 47 payments from 11 companies in 2025. Trend: 2023 $1,058 · 2024 $978 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $223 |
| AstraZeneca Pharmaceuticals LP | 9 | $206 |
| ABBVIE INC. | 9 | $145 |
| Lilly USA, LLC | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Amgen Inc. | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Boston Scientific Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: NURTEC ODT, BREZTRI, FARXIGA, PREVNAR 20, QULIPTA, JARDIANCE, VRAYLAR, ELIQUIS.
Industry payments across MS — which companies pay providers there.
